Skip to main content
General Medicine

Blinatumomab



General

Pronunciation

(blin a TOOM oh mab)

Brand Names: U.S.

  • Blincyto

Indications

Use: Labeled Indications

Acute lymphoblastic leukemia, minimal residual disease–positive (CD19-positive): Treatment of CD19-...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

START 10-DAY FREE TRIAL
Subscribe Now
©2022 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved.

Enter An Access Code

 
We are unable to redeem your access code. Please try again another time.
Enter the code from your copy of The 5-Minute Clinical Consult or another access code to create an account.
×
×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept